Skip to content

Public FDA record

Z-0295-04: POLYMEDCO ULTRA-CRP High Sensitive Assay For the DIMENSION(R) systems, Catalog No. USC300. Contents: 4 x

Recall record Z-0295-04 for Polymedco, Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0295-04
Company in FDA record
Polymedco, Inc
FDA classification date
Jan 6, 2004
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Firm was notified by the foreign manufacturer that certain lots of Ultra-CRP are prone to prozone (a condition of antibody antigen excess) and do not meet the labeled specifications.

Source facts

Action
By phone on 12/3/03 and by mail on 12/5/03.
Initiated
2003-12-03
Root cause
Other
Terminated
2005-04-20
Distribution
Medical facilities, physicians, diagnostic laboratories, and distributors located nationwide.
Recall number
Z-0295-04
Recall status
Terminated
CDRH record ID
30670
FDA classified
2004-01-06
Recall event number
27874

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗